drugset / Trial / NCT02235558

Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke

NCT02235558

Phase 1 Completed 11 enrolled Justin Fraser
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether super-selective intra-arterial administration of verapamil immediately following successful intra-arterial thrombolysis is safe as a potential neuroprotective agent. Standard procedures are cerebral angiography and intra-arterial thrombolysis (intra-arterial administration of tPA and/or mechanical thrombectomy). Experimental procedure is superselective injection of verapamil intra-arterially.

Timeline

Start
2013-02-01
Primary completion
2016-03-21
Completion
2016-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Verapamil Other / unclassified 10 mg Other

Indications